Naturalistic, self-assignment comparative trial of bupropion SR, a nicotine patch, or both for smoking cessation treatment in primary care

American Journal on Addictions

Volumn 11, Issue 4, 2002, Pages 315-331

  Gold, Paul B ^a   Rubey, Robert N ^a   Harvey, Richard T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BUPROPION SR; NICOTINE;

ADULT; ANXIETY DISORDER; ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; EDEMA; FEMALE; HEADACHE; HUMAN; INSOMNIA; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NEURASTHENIA; PRIMARY HEALTH CARE; SELF REPORT; SIDE EFFECT; SMOKING CESSATION; THORAX PAIN; THOUGHT DISORDER; TOBACCO DEPENDENCE; TREATMENT OUTCOME;

EID: 0036755586     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1080/1055049029008811     Document Type: Article

References (65)

1. Carroll KM. Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes. Addict Beh. 1997;22:233-245.
2. Shiffman S. Smoking cessation treatment: Any progress? J Consult Clin Psychol. 1993;61:718-722.
3. Carroll KM, Schottenfeld R. Nonpharmacological approaches to substance abuse treatment. Med Clin North Am. 1997;81:927-944.
4. Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Int Med. 1995;155:1933-1941.
5. Hughes JR, Goldstein MG, Hurt RD, et al. Recent advances in the pharmacotherapy of smoking cessation. JAMA. 1999;281:72-76.
6. Hughes JR, Stead LF, Lancaster T. Antidepressants for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software; 2002.
7. Ferry LH, Robins AS, Scariati PD, et al. Enhancement of smoking cessation using the antidepressant bupropion hydrochloride. Circulation. 1992;86(4Suppl1):I-671.
8. Ferry LH, Burchette RJ. Efficacy of bupropion for smoking cessation in non-depressed smokers. J Addict Dis. 1994;13:249.
9. Gonzales D, Nides MA, Ferry LH, et al. Bupropion SR as an aid to smoking cessation in smokers previously treated with bupropion: A randomized placebo-controlled study. Clin Pharmacol Ther. 2001;69:438-444.
10. Hertzberg MA, Moore SD, Feldman ME, Beckman JC. A preliminary study of bupropion sustained-release for smoking cessation in patients with chronic posttraumatic stress disorder. J Clin Psychopharmacol. 2001;21:94-98.
11. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-released bupropion and placebo for smoking cessation. N Engl J Med. 1997;337:1195-1202.
12. Jorenby DE, Leischow SJ, Nides MA, et al. A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation. N Engl J Med. 1999;340:685-691.
13. Tashkin D, Kanner R, Bailey W, et al. Smoking cessation in patients with chronic obstructive pulmonary disease: A double-blind, placebo-controlled, randomized trial. Lancet. 2001;357:1571-1575.
14. Silagy C, Lancaster T, Stead L, Mant T, Fowler G. Nicotine replacement therapy for smoking cessation (Cochrane Review). In: The Cochrane Library, Issue 2. Oxford: Update Software; 2002.
15. Blondal T, Gudmundsson LJ, Olafsdottir I, et al. Nicotine nasal spray with nicotine patch for smoking cessation: Randomized trial with six-year follow up. BMJ. 1999;318:285-288.
16. Kornitzer M, Boutsen M, Dramiax M, et al., Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med. 1995;24:41-47.
17. Fagerstrom K-O. Combined use of nicotine replacement products. Health Values. 1994;18:15-20.
18. Puska P, Bjorkqvist S, Koskela K. Nicotine-containing chewing gum in smoking cessation: A double blind trial with half year follow-up. Addict Behav. 1979;4:141-146.
19. Bohadana A, Nilsson F, Rasmussen T, Martinet Y. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation - A randomized, double-blind, placebo-controlled trial. Arch Intern Med. 2000;160:3128-3134.
20. Hajek P, West R, Foulds J, et al. Randomized comparative trial of nicotine polacrilex, a transdermal patch, nasal spray, and an inhaler. Arch Intern Med. 1999;159:2033-2038.
21. Davidson M, Epstein M, Burr R, Schaefer C, Whitworth G, McDonald A. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch Fam Med. 1998;7:569-574.
22. Hays JT, Croghan GA, Offord KP, Hurt RD, Schroeder DR, Wolter TD, Nides MA, Davidson M. Over-the-counter nicotine patch therapy for smoking cessation: Results from randomized, double-blind, placebo-controlled and open label trials. Am J Public Health. 1999;89:1701-1707.
23. Jolicoeur DG, Ahluwalia JS, Richter K, et al. The use of nicotine patches with minimal intervention. Prev Med. 2000;30:504-512.
24. Leischow SJ, Muramoto ML, Cook GN, Merikle EP, Castellini SM, Otte PS. OTC nicotine patch: Effectiveness alone and with brief physician intervention. Am J Health Behav. 1999;23:61-69.
25. Shiffman S, Pinney JM, Gitchell J, et al. Public health benefit of over-the-counter nicotine medications. Tob Control. 1997;6:306-310.
26. Shiffman S, Rolf CN, Hellebush SJ, et al. Real-world efficacy of prescription and overthe-counter nicotine replacement therapy. Addiction. 2002;97:505-516.
27. Abrams DB, Orleans CT, Niaura RS, et al. Treatment issues: Towards a stepped care model. Tob Control. 1993:2(suppl):S17-S37.
28. Kizer KW. Transforming the Veterans health care system - The "New VA." JAMA. 1996;275:1069-1072.
29. Shortell SM, Gillies RR, Anderson, DA. The new world of managed care: Creating organized delivery systems. Health Aff (Millwood). 1994;13:46-64.
30. Badger LW, deGruy 3rd FV, Hartman J, et al. Psychosocial interest, medical interviews, and the recognition of depression. Arch Fam Med. 1994;3:899-907.
31. Krupnick JL, Sotsky SM, Simmens S, et al. The role of therapeutic alliance in psychotherapy and pharmacotherapy outcome: Findings in the National Institute of Mental Health Treatment of Depression Collaborative Research Program. J Consult Clin Psychol. 1996;64:532-539.
32. Laine C, Davidoff F. Patient-centered medicine: A professional evolution. JAMA. 1996;275:152-156.
33. Cooper-Patrick L, Gallo JJ, Gonzales JJ, et al. Race, gender, and partnership in the patient-physician relationship. JAMA. 1999;282:583-589.
34. Braddock CH, Edwards EA, Hasenberg NM, et al. Informed decision making in outpatient practice: Time to get back to basics. JAMA. 1999;282:2313-2320.
35. Lichtenstein E, Hollis JF. Patient referral to a smoking cessation program: Who follows through? J Fam Practice. 1992;34:739-744.
36. The Agency for Health Policy and Research. Smoking cessation clinical practice guideline. JAMA. 1996;275:1270-1280.
37. Hughes JR, Fiester S, Goldstein MG, et al. American Psychiatric Association practice guideline for the treatment of patients with nicotine dependence. Am J Psychiatry. 1996;153(suppl):S1-S31.
38. Lichtenstein E, Glasgow RE, Lando HA, et al. Telephone counseling for smoking cessation: Rationales and meta-analytic review of evidence. Health Educ Res. 1996;11:243-257.
39. Wadland WC, Stoffelmayr B Berger E, et al. Enhancing smoking cessation rates in primary care. J Fam Pract. 1999;48:711-718.
40. Link BG, Phelan JC, Bresnahan M, et al. Public conceptions of mental illness: Labels, causes, dangerousness, and social distance. Am J Public Health. 1999;89:1328-1333.
41. Pescosolido BA, Monahan J, Link BG, et al. The public's view of the competence, dangerousness, and the need for legal coercion of persons with mental health problems. Am J Public Health. 1999;89:1339-1345.
42. Harrell AV. The validity of self-report drug use data: The accuracy of responses on confidential self-administered answer sheets. In: Harrison L, Hughes A, eds. The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates; 1997:37-58. NIDA Research Monograph No. 167.
43. Harrison L. The validity of self-reported drug use in survey research: An overview and critique of research methods. In: Harrison L, HughesA, eds. The Validity of Self-Reported Drug Use: Improving the Accuracy of Survey Estimates; 1997:17-36. NIDA Research Monograph No. 167.
44. Patrick DL, Cheadle A, Thompson DC, et al. The validity of self-reported smoking: A review and meta-analysis. Am J Public Health. 1994;84:1086-1093.
45. Velicer WF, Prochaska JO, Rossi JS, et al. Assessing outcome in smoking cessation studies. Psychol Bull. 1992;111:23-41.
46. Navarro AM. Smoking status by proxy and self report: Rate of agreement in different ethnic groups. Tob Control. 1999;8:182-185.
47. Klebanoff MA, Levine RJ, Clemens JD, et al. Serum cotinine concentration and self-reported smoking during pregnancy. Am J Epidemiol. 1998;148:259-262.
48. Peto R, Pike M, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer. 1977:35:1-39.
49. Pocock SJ. Clinical Trials: A Practical Approach. New York: Wiley; 1983.
50. Sheiner LB, Rubin DR. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther. 1995;57:6-15.
51. Lavori PW. Clinical trials in psychiatry: Should protocol deviation censor patient data? Neuropsychopharmacology 1992;6:39-48.
52. Rounsaville BJ, Weiss R, Carroll K. Options for managing psychotropic medications in drug-abusing patients participating in behavioral therapies clinical trials. Am J Addict. 1999;8:178-189.
53. Wells KB. Treatment research at the crossroads: The scientific interface of clinical trials and effectiveness research. Am J Psychiatry. 1999;156:5-10.
54. Wells KB, Sturm R. Informing the policy process: From efficacy to effectiveness data on pharmacotherapy. J Consult Clin Psychol. 1996;64:638-645.
55. Zarin DA, Pincus HA, West JC, et al. Practice-based research in psychiatry. Am J Psychiatry. 1997;154:1199-1208.
56. Centers for Disease Control and Prevention. Cigarette smoking-attributable mortality and years of potential life lost - United States, 1984. MMWR 1997;46:444-451.
57. McGinnis JM, Foege WH. Actual causes of death in the United States. JAMA. 1993;270:2207-2212.
58. Peto P, Lopez A, Boreham J, et al. Mortality from smoking worldwide. Br Med Bull. 1996;52:12-21.
59. Miller LS, Zhang X, Rice DP, et al. State estimates of total medical expenditures attributable to cigarette smoking. Public Health Rep. 1998;113:447-458.
60. Carroll KM. Manual-guided psychosocial treatment: A new virtual requirement for pharmacotherapy trials? Arch Gen Psychiatry. 1997;54:923-928.
61. Chambless DL, Hollon SD. Defining empirically supported therapies. J Consult Clin Psychol. 1998;1:7-18.
62. Bulpitt C. Randomized Controlled Clinical Trials, 2nd ed. Boston: Kluwer Academic; 1996.
63. Pocock SJ, Elbourne DR. Randomized trials or observational tribulations? N Engl J Med. 2000;342:1907-1909.
64. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887-1892.
65. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56:1073-1086.